Flat dose intravenous immunoglobulin (IVIG) for primary infection prophylaxis after CAR-T for B-cell non-Hodgkin lymphoma (B-NHL).Spencer Lessans, Vivek Patel, Bipin N. Savani et al.|Journal of Clinical Oncology|2024Cited by 2
Impact of Time from Referral to Treatment on Outcomes and Cost of Therapy for Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma: An Intention to Treat AnalysisVivek Patel, Shakthi Bhaskar, Katherine E. Baker et al.|Blood|2023Cited by 1
Patterns of Use and Impact of Post-Referral and Bridging Therapy on Outcomes in Patients Undergoing CAR T-Cell Therapy for B-Cell Lymphoma: A Single-Center AnalysisShakthi Bhaskar, Vivek Patel, Katherine E. Baker et al.|Blood|2023Cited by 0
Long-term outcomes after cardiac transplantation in AL amyloidosis.Spencer Lessans, Lynn Punnoose, Vivek Patel et al.|Journal of Clinical Oncology|2024Cited by 0